Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript

Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.26.

Keep Reading →